| 000 | 01879 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515182037.0 | ||
| 264 | 0 | _c20100727 | |
| 008 | 201007s 0 0 spa d | ||
| 022 | _a1578-1852 | ||
| 024 | 7 |
_a10.1016/j.eimc.2009.02.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRodríguez-Caravaca, Gil | |
| 245 | 0 | 0 |
_a[Hepatitis C outbreak in an oncology ward]. _h[electronic resource] |
| 260 |
_bEnfermedades infecciosas y microbiologia clinica _cApr 2010 |
||
| 300 |
_a233-5 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCatheter-Related Infections _xepidemiology |
| 650 | 0 | 4 |
_aCatheterization, Central Venous _xadverse effects |
| 650 | 0 | 4 |
_aCross Infection _xepidemiology |
| 650 | 0 | 4 | _aDisease Outbreaks |
| 650 | 0 | 4 | _aDrug Contamination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 |
_aHepatitis C _xepidemiology |
| 650 | 0 | 4 | _aHospitals, University |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 | _aOncology Service, Hospital |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSodium Chloride _xadverse effects |
| 650 | 0 | 4 |
_aSpain _xepidemiology |
| 700 | 1 | _aVillar-del-Campo, María Concepción | |
| 700 | 1 | _aCasas-Losada, María Luisa | |
| 700 | 1 | _aCava-Valenciano, Fernando | |
| 700 | 1 | _aGil-de-Miguel, Angel | |
| 773 | 0 |
_tEnfermedades infecciosas y microbiologia clinica _gvol. 28 _gno. 4 _gp. 233-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eimc.2009.02.015 _zAvailable from publisher's website |
| 999 |
_c19054138 _d19054138 |
||